Appropriate and effective management of rheumatoid arthritis
Open Access
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (6) , 627-633
- https://doi.org/10.1136/ard.2003.011395
Abstract
Early referral (at <3 months) and early DMARD treatment enable the course of RA to be changed. Once the disease has become aggressive it is much harder to treat and improvements will not be as great as they would have been with earlier treatment. The latest strategies and treatments enable remission to be achieved in many more patients than formerly.Keywords
This publication has 37 references indexed in Scilit:
- Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trialArthritis & Rheumatism, 2003
- The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD coursesRheumatology, 2002
- Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three yearsAnnals of the Rheumatic Diseases, 2002
- Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesArthritis & Rheumatism, 2002
- Follow up studies in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2002
- Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guideAnnals of the Rheumatic Diseases, 2002
- Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositisAnnals of the Rheumatic Diseases, 2002
- Future prospects for anti-cytokine treatmentAnnals of the Rheumatic Diseases, 2000
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994